Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

154
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
154
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

135
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
135

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supplementation of calcium, magnesium, phosphate, and potassium in critically ill patients: A multicenter cohort study.

PloS one·2026
Same author

Dynamic Changes in Tumor Burden in Patients Undergoing PSMA RLT.

European urology oncology·2026
Same author

Association of travel nursing with quality outcomes in hospitalized patients.

The American journal of managed care·2026
Same author

Does Patient Experience Correlate With Overall Hospital Quality Ratings?

Journal of patient experience·2026
Same author

Association Between Post-Operative Serum Lactate, Fluid Administration, and Outcome in Living Donor Liver Transplant Recipients: A Ten-Year Experience.

Journal of intensive care medicine·2026
Same author

Event rates of patients with stable heart failure with reduced ejection fraction and newly diagnosed obstructive or central sleep apnoea.

European journal of heart failure·2026
Same journal

Correction: VExUS score: optimizing its use in perioperative and critical care management.

Critical care (London, England)·2026
Same journal

Optimizing β-lactam antibiotics with the highest concentration-for continuous infusion reduce carbon footprint in intensive care.

Critical care (London, England)·2026
Same journal

Physiological and clinical effects of selected airway clearance techniques in mechanically ventilated adult ICU patients: a systematic review and synthesis without meta-analysis.

Critical care (London, England)·2026
Same journal

How we use the neurological pupil index (NPi).

Critical care (London, England)·2026
Same journal

45th International Symposium on Intensive Care & Emergency Medicine.

Critical care (London, England)·2026
Same journal

High-resolution monitoring reveals fragmented 24-hour light exposure in intensive care units.

Critical care (London, England)·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

179

Bayesian methods: a potential path forward for sepsis trials.

George Tomlinson1, Ali Al-Khafaji2, Steven A Conrad3

  • 1Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.

Critical Care (London, England)
|November 8, 2023
PubMed
Summary
This summary is machine-generated.

Bayesian statistical methods enhance clinical trial power for sepsis by incorporating historical data. This approach offers a viable alternative to conventional designs, improving the detection of beneficial treatments in critical care.

Keywords:
EndotoxemiaEndotoxin septic shockHemadsorptionPolymyxin-BSeptic shockStatistical methodsTrial simulation

More Related Videos

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.1K
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.5K

Related Experiment Videos

Last Updated: Jul 11, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

179
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.1K
Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.5K

Area of Science:

  • Critical care medicine
  • Biostatistics
  • Clinical trial design

Background:

  • Bayesian statistical methods are increasingly considered for complex conditions like sepsis, building on successes in COVID-19 platform trials.
  • Designing Bayesian trials requires careful consideration of how statistical power is affected by incorporating historical data via prior distributions.
  • The heterogeneity of sepsis necessitates robust statistical approaches to ensure trial efficacy.

Purpose of the Study:

  • To assess the influence of different historical data incorporation methods (prior distributions) and analysis types on Bayesian trial outcomes for sepsis.
  • To evaluate how statistical power varies with Bayesian methods based on the utilization of historical data.
  • To compare Bayesian trial designs with conventional approaches that disregard historical data.

Main Methods:

  • A simulation study was conducted using historical data from a polymyxin B hemadsorption trial for endotoxemic septic shock.
  • The historical data comprised 179 adult patients with septic shock, multiple organ failure, and specific endotoxin activity levels.
  • Simulations explored various ways of incorporating historical data into the prior distribution for a proposed 150-patient trial.

Main Results:

  • Simulations demonstrated increased statistical power when clinically justifiable historical data were incorporated into Bayesian analyses.
  • For an observed mortality reduction from 44% to 37%, Bayesian methods yielded a 96% probability of benefit (75% prior weight) or 90% (adaptive prior).
  • Ignoring historical data resulted in only an 80% probability of benefit for the same observed outcome.

Conclusions:

  • Utilizing Bayesian methods with historical data in prior distributions enhances study power compared to conventional designs that ignore such data.
  • Bayesian approaches offer a promising strategy for clinical trials in critical care, particularly for identifying effective treatments for elusive conditions.
  • This methodology provides a statistically sound framework for designing more powerful trials in critical care settings.